Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP TMS S.A. Reports 2007 Fourth Quarter and Year End Preliminary Unaudited Revenues
Record Fourth Quarter Revenue Financial Highlights: Full year revenues of Euro 22.2 million, up 10% year-over-year Record fourth quarter revenue of Euro 7.0 million, up 43% year-over-year Robust 42% full year revenue attributed to Ablatherm-HIFU Ablatherm-HIFU RPP treatments increased 36% year-over-year; 40% from fourth quarter 2006 Approximately 3,400 Ablatherm-HIFU treatments worldwide for year, yielding 15,000 cumulative treatments at 176 clinical sites Successful launch of integrated Sonolith I-Sys for the disintegration of urinary stones
View HTML
Toggle Summary EDAP TMS S.A. to Launch GmbH Subsidiary Entity in Germany
Subsidiary Formed in Response to Market Success, Ongoing Expansion Leipzig Site Launches Fixed RPP Model with Contract Commitment
View HTML
Toggle Summary EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook
EDAP TMS S.A. to Participate in German Conference, Updates Growth Outlook Lyon, France, September 19, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced a series of events centered around the DGU Conference in
View HTML
Toggle Summary EDAP TMS S.A. to Participate in International Urology Conferences
EDAP TMS S.A. to Participate in International Urology Conferences LYON, France -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, today announces it is actively participating in the Societe Internationale d'Urologie (SIU)
View HTML
Toggle Summary EDAP TMS S.A. To Present 10-Year Results, Live Ablatherm Treatments at EAU Congress
Distributor Meeting, User Group Sessions, Media Conferences to Highlight Ablatherm-HIFU
View HTML
Toggle Summary EDAP TMS S.A. to Present at Roth Capital Conference in New York
EDAP TMS S.A. to Present at Roth Capital Conference in New York Lyon, France, August 24, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announced management will present at the Roth Capital Partners New York
View HTML
Toggle Summary EDAP TMS S.A. to Present at the Roth Capital 2007 Orange County Conference
EDAP TMS S.A. to Present at the Roth Capital 2007 Orange County Conference Lyon, France, February 16, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and
View HTML
Toggle Summary EDAP TMS S.A. to Release 2006 Second Quarter Financial Results August 8, 2006
EDAP TMS S.A. to Release 2006 Second Quarter Financial Results August 8, 2006 Lyon, France, August 3, 2006 - EDAP TMS S.A. (Nasdaq: EDAP) , will release its second quarter financial results for the period ending June 30, 2006 on Tuesday, August 8, 2006 after the market close.
View HTML
Toggle Summary EDAP TMS S.A. to Release 2006 Year End Financial Results
EDAP TMS S.A. to Release 2006 Year End Financial Results Lyon, France, March 5, 2007 - EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution of a wide
View HTML
Toggle Summary EDAP TMS S.A. to Release 2007 First Quarter Results
EDAP TMS S.A. to Release 2007 First Quarter Results LYON, France , May 7 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and the international leader in the development, production, and distribution
View HTML